Higher preprocedural fibrinogen levels are associated with aneurysm sac regression after EVAR
Abstract
Summary.Background: The aim of our study was to determine the diameter of the aneurysm sac 24 months after endovascular abdominal aortic aneurysm repair (EVAR); to identify factors associated with sac regression, and to determine the impact of sac regression on all-cause mortality during long-term follow-up. Patients and methods: We conducted a retrospective review of prospectively collected data from patients treated with EVAR between January, 2010 and July, 2016. Sac regression was defined as at least 5 mm decrease in aneurysm diameter in relation to the preprocedural diameter seen on computed tomography angiography. Sociodemographic information, comorbidities, treatment, laboratory parameters, selected anatomical and genetic factors were all analysed to determine their impact on sac regression. Results: During the study period, 124 patients with mean age of 71.2 ± 7.2 years met the inclusion criteria. Sac regression was found in 45.2% of patients. Higher preprocedural fibrinogen was found in patients with sac regression in comparison with patients with stable sac or sac expansion (3.84 g/l vs 3.47 g/l; p = 0.028). In multivariate analysis after adjustment for age, hypertension, sex, smoking, dyslipidaemia, volume and percentage of intraluminal thrombus higher fibrinogen was associated with an increased probability of sac regression (OR 2.47; 95% CI 1.29–4.72; p = 0.006). Persistent type II endoleak was associated with significantly lower probability of sac regression in univariate and multivariate analysis after adjustment for age, hypertension, sex, smoking and dyslipidaemia (OR 0.26; 95% CI 0.10–0.66; p = 0.004). Higher age was a significant predictor of sac regression in multivariate analysis after adjustment for hypertension, sex, smoking and dyslipidaemia (OR 1.07; 95% CI 1.02–1.14; p = 0.012). No difference was found between patient subgroups with and without sac regression in all-cause mortality during follow-up. Conclusions: Higher preprocedural fibrinogen, absence of persistent type II endoleak and higher age were predictive factors of aneurysm sac regression post-EVAR.
References
1 , Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival. J Vasc Surg. 2019;69(2):414–422.
2 , Early sac shrinkage predicts a low risk of late complications after endovascular aortic aneurysm repair. Br J Surg. 2014;101(7):802–10.
3 , Long-term results after endovascular abdominal aortic aneurysm repair using the Cook Zenith endograft. Vasc Surg. 2011;54(1):48–57.
4 , Late Sac Behavior after Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm. Ann Vasc Dis. 2016;9(2):102–107.
5 , Influencing factors of sac shrinkage after endovascular aneurysm repair. J Vasc Surg. 2017;65(6):1830–1838.
6 , Risk factors associated with late aneurysmal sac expansion after endovascular abdominal aneurysm repair. Diagn Interv Radiol. 2015;21(3):195–201.
7 , Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair. Circulation. 2011;123(24):2848–55.
8 , Abdominal Aortic Aneurysm Genetic Associations: Mostly False? A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2016;51(1):64–75.
9 , The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2–77.
10 , 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. Eur Heart J. 2014;35:2873–2926.
11 , Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology. 2006;57(5):607–14.
12 , Impact of Age and Intraluminal Thrombus Volume on Abdominal Aortic Aneurysm Sac Enlargement after Endovascular Repair. Ann Vasc Surg. 2015;29(7):1440–6.
13 , Effect of stentgraft model on aneurysm shrinkage in 1,450 endovascular aortic repairs. Eur J Vasc Endovasc Surg. 2013;46(2):192–200.
14 , Coagulation, fibrinolysis, and platelet activation in patients undergoing open and endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 2011;54(3):865–78.
15 , Factors Associated with Development of Large Aneurysm in Middle-aged Men. Eur J Vasc Endovasc Surg. 2005;30(4):346–52.
16 , A systematic review and meta-analysis of the association between markers of hemostasis and abdominal aortic aneurysm presence and size. J Vasc Surg. 2014;59(2):528–535.
17 , Plasma fibrinogen and D-dimer concentrations are associated with the presence of abdominal aortic aneurysm: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2009;38(3):273–7.
18 , Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br J Radiol. 2000;73:1034–1041.
19 , Changes in platelet activity and tissue plasminogen activator during arteriography in patients with chronic limb ischaemia. Thromb Res. 1992;65:663–5.
20 , The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding. Thromb Res. 2011;128(Suppl 1):S13–6.
21 , Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood. 2011;117(18):4953–4963.
22 , Association Between Perioperative Fibrinogen Levels and the Midterm Outcome in Patients Undergoing Elective Endovascular Repair of Abdominal Aortic Aneurysms. Ann Vasc Surg. 2018;Nov 27. pii: S0890–5096(18)30900-2. doi: 10.1016/j.avsg.2018.09.021. [Epub ahead of print] PMID: 30500639
23 , Changes in inflammatory, coagulopathic, and fibrinolytic responses after endovascular repair of an abdominal aortic aneurysm: relationship between fibrinogen degradation product levels and endoleaks. Jpn J Radiol. 2014;32(6):347–55.
24 , Circulating biomarkers are not associated with endoleaks after endovascular repair of abdominal aortic aneurysms. J Vasc Surg. 2018;67(3):770–777.
25 , Metabolic syndrome is associated with type II endoleak after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2014;59(4):938–43.
26 , Role of type II endoleak in sac regression after endovascular repair of infrarenal abdominal aortic aneurysm. J Vasc Surg. 2015;61(4):869–74.
27 , Risk factors and consequences of persistent type II endoleaks. J Vasc Surg. 2016;63(4):895–901.
28 , Significance of endoleaks after endovascular repair of abdominal aortic aneurysms: The EUROSTAR experience. J Vasc Surg. 2002;35(3):461–73.
29 , Evaluation of potential outcome predictors in type II endoleak: a retrospective study with CT angiography feature analysis. AJR Am J Roentgenol. 2011;197(1):234–40.
30 , Dual-energy computed tomography after endovascular aortic aneurysm repair: the role of hard plaque imaging for endoleak detection. Eur Radiol. 2014;24(10):2449–57.
31 , Postoperative initial 2-day blood pressure management facilitates the shrinkage of abdominal aortic aneurysm after endovascular aneurysm repair by reducing the incidence of type II endoleak. J Vasc Surg. 2018;67(1):166–173.
32 , Effect of systemic blood pressure on aneurysm size in the presence of a type II endoleak. Vascular. 2008;16(6):321–5.
33 , Factors for Sac Size Change of Abdominal Aortic Aneurysm after Endovascular Repair. Ann Thorac Cardiovasc Surg. 2014;20:1016–1020.
34 , Calcium channel blockers enhance sac shrinkage after endovascular aneurysm repair. J Vasc Surg. 2012;55(6):1593–1599.
35 , Influence of warfarin therapy on the occurrence of postoperative endoleaks and aneurysm sac enlargement after endovascular abdominal aortic aneurysm repair. Interact Cardiovasc Thoracic Surg. 2017;24(4):615–618.
36 , Statin therapy is associated with aneurysm sac regression after endovascular aortic repair. J Vasc Surg. 2012;55(6):1587–92.
37 , Influence of Statin Therapy on Aneurysm Sac Regression after Endovascular Aortic Repair. J Vasc Interv Radiol. 2017;28(1):35–43.
38 , Preoperative predictive factors of aneurysmal regression using the reporting standards for endovascular aortic aneurysm repair. J Vasc Surg. 2012;55(5):1287–95.
39 , Aneurysm sac expansion is independently associated with late mortality in patients treated with endovascular aneurysm repair. J Vasc Surg. 2018;67(1):157–164.
40 , Sample size and statistical power calculation in genetic association studies. Genomics Inform. 2012;10(2):117–122.